Aliases & Classifications for Vein Disease

MalaCards integrated aliases for Vein Disease:

Name: Vein Disease 12 14
Disorder of Vein 69

Classifications:



External Ids:

Disease Ontology 12 DOID:866
ICD10 33 I82 I87 I87.8
ICD9CM 35 453
SNOMED-CT 64 195435006
UMLS 69 C0155774

Summaries for Vein Disease

Disease Ontology : 12 A vascular disease that is located in a vein.

MalaCards based summary : Vein Disease, also known as disorder of vein, is related to venous insufficiency and multicentric osteolysis nephropathy, and has symptoms including vein pain An important gene associated with Vein Disease is F2 (Coagulation Factor II, Thrombin), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Collagen chain trimerization. The drugs Dalteparin and Heparin have been mentioned in the context of this disorder. Affiliated tissues include liver, heart and lung, and related phenotypes are homeostasis/metabolism and mortality/aging

Related Diseases for Vein Disease

Diseases related to Vein Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 175)
id Related Disease Score Top Affiliating Genes
1 venous insufficiency 10.9
2 multicentric osteolysis nephropathy 10.9 F5 MTHFR
3 variably protease-sensitive prionopathy 10.9 F2 F5
4 coronary sinus stenosis 10.9 F5 MTHFR
5 non-hodgkin lymphoma, during pregnancy 10.8 ALB F2
6 porphyria 10.8 F2 MTHFR
7 amelogenesis imperfecta hypomaturation type 10.8 F5 MTHFR
8 neuromyelitis optica 10.8 MTHFR PROC
9 lockwood feingold syndrome 10.7 F2 F5 MTHFR
10 pregnancy loss, recurrent 1 10.7 F5 MTHFR
11 primary pigmented nodular adrenocortical disease 10.7 F2 F5 MTHFR
12 stoll alembik finck syndrome 10.7 F5 SERPINC1
13 homologous wasting disease 10.7 F2 F5 MTHFR
14 bile duct cystadenoma 10.7 F2 F5
15 hepatocellular adenoma 10.7 F2 F5 MTHFR
16 oral cavity carcinoma in situ 10.7 ALB F2
17 collagenous colitis 10.7 F2 F5 SERPINC1
18 glutathioninuria 10.7 F2 F5 SERPINC1
19 bernard-soulier syndrome, type a2 10.6 F2 MTHFR SERPINC1
20 charcot-marie-tooth disease 10.6 F2 F5 MTHFR
21 mental retardation dysmorphism hypogonadism diabetes 10.6 F5 PROC SERPINC1
22 acute lymphocytic leukemia 10.6 ALB F2 F5
23 mediastinum leiomyoma 10.6 ALB F2 MTHFR
24 childhood brain stem glioma 10.6 ALB F2 SERPINC1
25 female infertility of uterine origin 10.6 ALB F2
26 preeclampsia/eclampsia 1 10.6 F5 MTHFR SERPINC1
27 pancreatic cystadenocarcinoma 10.6 ALB F2
28 duane retraction syndrome 10.6 AFP ALB F2
29 ischemic heart disease 10.6 ALB F2 SERPINC1
30 cataract 10.6 ALB SERPINC1
31 primary cerebellar degeneration 10.6 F5 MTHFR SERPINC1
32 portal vein thrombosis 10.6
33 sagittal sinus thrombosis 10.5 F3 SERPINC1
34 hereditary amyloidosis 10.5 F3 SERPINC1
35 syndactyly, mesoaxial synostotic, with phalangeal reduction 10.5 F2 PLG SERPINC1
36 exophthalmic ophthalmoplegia 10.5 ALB F5 SERPINC1
37 littre gland carcinoma 10.5 F2 PLG SERPINC1
38 syncope 10.5 F2 F5 MTHFR SERPINC1
39 superior limbic keratoconjunctivitis 10.5 F2 F5 MTHFR SERPINC1
40 hiv-1 10.5 F2 F5 MTHFR SERPINC1
41 sulfhemoglobinemia 10.5 F3 PLG
42 angular blepharoconjunctivitis 10.5 F2 F5 MTHFR SERPINC1
43 ulcerative stomatitis 10.5 F2 F5 MTHFR SERPINC1
44 joint disorders 10.5 F2 F5 MTHFR SERPINC1
45 sacrococcygeal teratoma 10.5 F2 F5 MTHFR SERPINC1
46 luminal breast carcinoma 10.5 AFP ALB
47 bubonic plague 10.5 ALB F2 SST
48 dentine erosion 10.5 F2 F5 MTHFR SERPINC1
49 venezuelan hemorrhagic fever 10.5 PLAT SERPINC1
50 angioedema, hereditary, type iii 10.4 F3 F5 SERPINC1

Graphical network of the top 20 diseases related to Vein Disease:



Diseases related to Vein Disease

Symptoms & Phenotypes for Vein Disease

UMLS symptoms related to Vein Disease:


vein pain

MGI Mouse Phenotypes related to Vein Disease:

44 (show all 13)
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.39 ADAM17 AFP ALB EPAS1 EVL F2
2 mortality/aging MP:0010768 10.32 EPAS1 EVL F2 F3 F5 F8
3 cardiovascular system MP:0005385 10.3 ADAM17 EPAS1 EVL F2 F3 F5
4 growth/size/body region MP:0005378 10.24 ADAM17 EPAS1 F2 F3 F5 MTHFR
5 hematopoietic system MP:0005397 10.22 ADAM17 EPAS1 EVL F2 F3 F8
6 immune system MP:0005387 10.17 ADAM17 EPAS1 EVL F2 F3 F8
7 embryo MP:0005380 10.11 PARVA PROS1 SERPINC1 ADAM17 EPAS1 F2
8 nervous system MP:0003631 10.07 PROC PROS1 SERPINC1 SST EVL F2
9 liver/biliary system MP:0005370 10.01 AFP ALB EPAS1 F5 PLG PROC
10 muscle MP:0005369 9.92 ADAM17 ALB EPAS1 F3 PARVA PLAT
11 reproductive system MP:0005389 9.76 ADAM17 AFP F2 F8 MTHFR PLAT
12 respiratory system MP:0005388 9.5 ADAM17 EPAS1 F2 F3 PLAT PLG
13 vision/eye MP:0005391 9.17 ADAM17 EPAS1 F3 MTHFR PLAT PLG

Drugs & Therapeutics for Vein Disease

Drugs for Vein Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1247)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dalteparin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6
2
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6 772 46507594
3
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 1 50-28-2 5757
4
Norethindrone Approved Phase 4 68-22-4 6230
5
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
6
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Phase 1 10102-43-9 145068
7
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 73590-58-6 4594
8
Pantoprazole Approved Phase 4 102625-70-7 4679
9
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
10
Esmolol Approved Phase 4 103598-03-4, 81147-92-4 59768
11
Nicardipine Approved Phase 4 55985-32-5 4474
12
Octreotide Approved, Investigational Phase 4,Phase 2,Phase 3 83150-76-9 383414 6400441
13
Somatostatin Approved Phase 4,Phase 2,Phase 3 38916-34-6, 51110-01-1 53481605
14
Terlipressin Approved, Investigational Phase 4 14636-12-5 72081
15
Cytarabine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 147-94-4 6253
16
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 21679-14-1, 75607-67-9 30751
17
Vidarabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 24356-66-9 32326 21704
18
Bivalirudin Approved, Investigational Phase 4,Phase 1 128270-60-0 16129704
19
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-61-7 60961
20
Nicorandil Approved Phase 4 65141-46-0 47528
21
Menthol Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 2216-51-5 16666
22
Warfarin Approved Phase 4,Phase 2,Phase 3,Phase 1 81-81-2 6691 54678486
23
Asparaginase Approved Phase 4,Phase 2 9015-68-3
24
Daunorubicin Approved Phase 4,Phase 2 20830-81-3 30323
25
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-02-2 5743
26
Idarubicin Approved Phase 4,Phase 2,Phase 1 58957-92-9 42890
27
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
28
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
29
Carboplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
30
Ethanol Approved Phase 4,Phase 2,Phase 3,Phase 1 64-17-5 702
31
Ethiodized oil Approved Phase 4,Phase 2,Phase 3 8008-53-5
32
Sorafenib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 284461-73-0 216239 406563
33
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2 55-56-1 9552079 2713
34
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 22916-47-8 4189
35
Bevacizumab Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 216974-75-3
36
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
37 Racepinephrine Approved Phase 4,Phase 3,Phase 2
38
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61825-94-3 5310940 9887054 43805 6857599
39
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
40
Cetuximab Approved Phase 4,Phase 1,Phase 2 205923-56-4 56842117 2333
41
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1 51-21-8 3385
42
Rivaroxaban Approved Phase 4,Phase 3,Phase 2,Phase 1 366789-02-8
43
Tranexamic Acid Approved Phase 4,Phase 2,Phase 3 1197-18-8 5526
44
Tranylcypromine Approved Phase 4 155-09-9 441233
45
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1 347396-82-1 459903
46
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 124-94-7 31307
47
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 10118-90-8 5281021
48
Ketamine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 6740-88-1 3821
49
Midazolam Approved, Illicit Phase 4,Phase 2,Phase 3,Phase 1 59467-70-8 4192
50
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337

Interventional clinical trials:

(show top 50) (show all 4666)

id Name Status NCT ID Phase Drugs
1 Compression Aided Management of Edema in Patients With C3 Venous Disease Unknown status NCT00766974 Phase 4
2 ClosureFAST - Radiofrequency Great Saphenous Vein Treatment Unknown status NCT00842296 Phase 4
3 Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis Unknown status NCT01245998 Phase 4 Dalteparin;Dalteparin
4 Rosuvastatin for Preventing Deep Vein Thrombosis Unknown status NCT01021488 Phase 4 Rosuvastatin 20mg/d for 14days;enoxaparin only
5 Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis Unknown status NCT00640731 Phase 4
6 Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings Unknown status NCT01793194 Phase 4
7 Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy Unknown status NCT02264743 Phase 4 Femoston Conti;EVOREL® CONTI
8 Comparison of Stent and Prothesis Bypass in Superficial Femoral Artery Unknown status NCT01147419 Phase 4
9 Far Infrared Therapy on AV Fistula Flow, Endothelial Function and Echocardiography in ESRD Patients Unknown status NCT01138254 Phase 4
10 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4 omeprazole;Pantoprazole
11 Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) Unknown status NCT00813332 Phase 4 Endostar(rh recombinant endostatin) plus Docetaxel;Placebo plus Docetaxel
12 Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery Unknown status NCT01171911 Phase 4 Nicardipine , Esmolol
13 Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding Unknown status NCT00966355 Phase 4 Terlipressin;Somatostatin;Octreotide
14 AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy Unknown status NCT02024308 Phase 4 Fludarabine;Cytarabine
15 Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI Unknown status NCT00476944 Phase 4
16 Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement Unknown status NCT01331902 Phase 4
17 Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children Unknown status NCT02515201 Phase 4 Taurolidine;Heparin
18 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II) Unknown status NCT01173094 Phase 4
19 Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients Unknown status NCT01610141 Phase 4
20 Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia Unknown status NCT01990807 Phase 4 Idarubicin(IDA)
21 Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma Unknown status NCT01833299 Phase 4
22 Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium Unknown status NCT01783314 Phase 4
23 Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections Unknown status NCT01142934 Phase 4
24 Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis Unknown status NCT00450645 Phase 4 low molecular weight heparin
25 Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery Unknown status NCT01229202 Phase 4 Bevacizumab
26 Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users Unknown status NCT01063426 Phase 4 High dose Atorvastatin+enoxaparin;Enoxaparin
27 Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism Unknown status NCT02127840 Phase 4 Synacthen infusion during adrenal venous sampling
28 A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC Unknown status NCT01997957 Phase 4 S-1
29 Pulmonary Vein (PV) -Isolation: Arrhythmogenic Vein(s) Versus All Veins Unknown status NCT00605748 Phase 4
30 Quadripolar Leads for the Management of Heart Failure Patients in the Middle East Unknown status NCT02195843 Phase 4
31 EZIO Compared to Central Venous Lines for Emergency Vascular Access Unknown status NCT00785252 Phase 4
32 Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor . Unknown status NCT02032303 Phase 4 Ticagrelor loading;Prasugrel loading
33 Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel Unknown status NCT02032290 Phase 4 ticagrelor loading;Clopidogrel loading
34 Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis Unknown status NCT01252420 Phase 4 Enoxaparin
35 Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Unknown status NCT02015650 Phase 4 Cetuximab;Mitomycin-C/ 5-Fluorouracil
36 Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty Unknown status NCT02453802 Phase 4 Tranexamic Acid 5%,5ml/amp;Tranexamic Acid 5%,5ml/amp;rivaroxaban (10mg);0.9% Normal Saline;0.9% Normal Saline
37 Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy Unknown status NCT01857544 Phase 4 Aflibercept
38 A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf® Unknown status NCT02011724 Phase 4
39 Retinal Sensitivity in BRVO After Anti-VEGF Therapy Unknown status NCT02527733 Phase 4 Ranibizumab;Ranibizumab and laser
40 Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis Unknown status NCT01350206 Phase 4
41 Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO Unknown status NCT00566761 Phase 4 bevacizumab and triamcinolone
42 A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy Unknown status NCT00773539 Phase 4
43 Comparative Study About the Impact of Two Oil Emulsions Administered Intravenously on Severe Acute Pancreatitis Unknown status NCT01376817 Phase 4 Fat emulsion with MCT, LCT, olive oil and omega 3 fatty acids;Fat emulsion with MCT and LCT
44 Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia Unknown status NCT01509274 Phase 4
45 Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage Unknown status NCT00699465 Phase 4 enoxaparin;enoxaparin placebo
46 Efficacy on Pain Following a Procedure for Injecting Sclerotherapeutic Foam Into the Great Saphenous Vein Completed NCT01368159 Phase 4
47 ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study. Completed NCT00509392 Phase 4
48 Iliac Vein Stenting in Advanced Chronic Venous Insufficiency Completed NCT02149212 Phase 4 Phlebotonic
49 Enoxaparin in Acute Venous Thromboembolic Disease Completed NCT00265993 Phase 4 enoxaparin
50 Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion Completed NCT01952353 Phase 4

Search NIH Clinical Center for Vein Disease

Genetic Tests for Vein Disease

Anatomical Context for Vein Disease

MalaCards organs/tissues related to Vein Disease:

39
Liver, Heart, Lung, Kidney, Brain, Testes, Bone

Publications for Vein Disease

Articles related to Vein Disease:

(show all 40)
id Title Authors Year
1
CHIVA - A prospective study of a vein sparing technique for the management of varicose vein disease. ( 28431588 )
2017
2
Evaluation of apoptosis in varicose vein disease complicated by superficial vein thrombosis. ( 25007903 )
2014
3
Cost analysis of endovenous catheter ablation versus surgical stripping for treatment of superficial venous insufficiency and varicose vein disease. ( 26992979 )
2014
4
Guidelines of the First International Consensus Conference on Endovenous Thermal Ablation for Varicose Vein Disease - ETAV Consensus Meeting 2012. ( 24534341 )
2014
5
Molecular characterization and population structure of blackberry vein banding associated virus, new Ampelovirus associated with yellow vein disease. ( 24126200 )
2013
6
One-shot scleroembolization: a new technique for the treatment of varicose veins disease of lower extremities. Preliminary results. ( 23934946 )
2013
7
Platelet distribution width and saphenous vein disease in patients after CABG. Association with graft occlusion. ( 22955688 )
2013
8
A review of familial, genetic, and congenital aspects of primary varicose vein disease. ( 22896013 )
2012
9
The significance of upper arm cephalic vein disease in vascular access creation. ( 23020965 )
2012
10
The hemodynamic paradox as a phenomenon triggering recurrent reflux in varicose vein disease. ( 23997567 )
2012
11
Increased vein wall apoptosis in varicose vein disease is related to venous hypertension. ( 21262580 )
2011
12
Superficial thrombophlebitis in varicose vein disease: the particular role of methylenetetrahydrofolate reductase. ( 21690171 )
2011
13
Superficial thrombophlebitis in varicose vein disease: the particular role of methylenetetrahydrofolate reductase. ( 20881312 )
2011
14
Molecular and biological characterization of pepper yellow vein Mali virus (PepYVMV) isolates associated with pepper yellow vein disease in Burkina Faso. ( 21080204 )
2011
15
Pathogenic mechanisms in varicose vein disease: the role of hypoxia and inflammation. ( 20632821 )
2010
16
Endovenous laser ablation for the treatment of recurrent varicose vein disease--a single centre experience. ( 20227536 )
2010
17
Minimally invasive vein surgery: latest options for vein disease. ( 20506452 )
2010
18
Chronic venous insufficiency: current management of varicose vein disease. ( 20336886 )
2010
19
Further evidence of Mirafiori lettuce big-vein virus but not of Lettuce big-vein associated virus with big-vein disease in lettuce. ( 18944196 )
2008
20
Changes in the wall of the great saphenous vein at consecutive stages in patients suffering from chronic vein disease of the lower limbs. ( 17985316 )
2007
21
The economics of vein disease. ( 17911565 )
2007
22
A begomovirus associated with Ageratum yellow vein disease in Indonesia: evidence for natural recombination between tomato leaf curl Java virus and Ageratum yellow vein virus-[Java]. ( 17294343 )
2007
23
Surgical correction of varicose vein disease under micronized diosmin protection (results of the Russian multicenter controlled trial DEFANS). ( 18004259 )
2007
24
The histopathology of varicose vein disease. ( 17067976 )
2006
25
Selection of saphenous vein conduit in varicose vein disease. ( 16564256 )
2006
26
The DNA beta satellite component associated with ageratum yellow vein disease encodes an essential pathogenicity protein (betaC1). ( 15183051 )
2004
27
Adaptation from whitefly to leafhopper transmission of an autonomously replicating nanovirus-like DNA component associated with ageratum yellow vein disease. ( 11907341 )
2002
28
Nucleotide sequence and genomic organization of an ophiovirus associated with lettuce big-vein disease. ( 12388823 )
2002
29
Pathogenicity of a natural recombinant associated with ageratum yellow vein disease: implications for geminivirus evolution and disease aetiology. ( 11259188 )
2001
30
A unique virus complex causes Ageratum yellow vein disease. ( 10841581 )
2000
31
A nanovirus-like DNA component associated with yellow vein disease of Ageratum conyzoides: evidence for interfamilial recombination between plant DNA viruses. ( 10544139 )
1999
32
Symptomatology of vein disease. ( 7728483 )
1995
33
Unsuspected preexisting saphenous vein disease: an unrecognized cause of vein bypass failure. ( 1728668 )
1992
34
The management of varicose vein disease. ( 287952 )
1979
35
The modern treatment of varicose vein disease. ( 4520459 )
1973
36
Phlebography in varicose vein disease. ( 5014478 )
1972
37
Mesenteric vein disease. ( 13740328 )
1961
38
Yellow-vein disease of citrus and studies of interactions between yellow-vein and other viruses of citrus. ( 13843232 )
1960
39
Pulmonary embolism; its incidence, significance, and relation to antecedent vein disease. ( 18111784 )
1949
40
Pulmonary embolism; its incidence, significance, and relation to antecedent vein disease. ( 18877800 )
1948

Variations for Vein Disease

Expression for Vein Disease

Search GEO for disease gene expression data for Vein Disease.

Pathways for Vein Disease

Pathways related to Vein Disease according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.93 ALB F2 F3 F5 F8 PLAT
2
Show member pathways
12.52 F2 F3 F5 F8 PROC PROS1
3
Show member pathways
11.82 F2 F3 F5 F8 PLAT PLG
4 11.69 F3 PARVA PLG
5
Show member pathways
11.67 F2 PROC PROS1
6 11.42 F2 F3 F5 F8 PLAT PLG
7 11.22 AFP ALB F2
8 10.96 ADAM17 PLAT PLG
9 10.67 F2 PROC PROS1
10 10.55 PLAT PLG

GO Terms for Vein Disease

Cellular components related to Vein Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 blood microparticle GO:0072562 9.72 ALB F2 PLG PROS1 SERPINC1
2 platelet alpha granule lumen GO:0031093 9.55 ALB F5 F8 PLG PROS1
3 Golgi lumen GO:0005796 9.54 F2 PROC PROS1
4 endoplasmic reticulum lumen GO:0005788 9.5 AFP ALB F2 F5 F8 PROC
5 extracellular space GO:0005615 9.4 AFP ALB F2 F3 F5 F8
6 extracellular region GO:0005576 10.03 AFP ALB F2 F3 F5 F8

Biological processes related to Vein Disease according to GeneCards Suite gene sharing:

(show all 13)
id Name GO ID Score Top Affiliating Genes
1 post-translational protein modification GO:0043687 9.91 AFP ALB EPAS1 F5 PROC SERPINC1
2 ER to Golgi vesicle-mediated transport GO:0006888 9.8 F2 F5 F8 PROC PROS1
3 response to hypoxia GO:0001666 9.78 ADAM17 EPAS1 MTHFR PLAT
4 platelet degranulation GO:0002576 9.72 ALB F5 F8 PLG PROS1
5 cellular protein metabolic process GO:0044267 9.7 AFP ALB F2 F5 PLG PROC
6 signal peptide processing GO:0006465 9.63 F2 PROC PROS1
7 blood coagulation GO:0007596 9.61 F2 F3 F5 F8 PLAT PLG
8 fibrinolysis GO:0042730 9.56 F2 PLAT PLG PROS1
9 peptidyl-glutamic acid carboxylation GO:0017187 9.54 F2 PROC PROS1
10 blood coagulation, intrinsic pathway GO:0007597 9.52 F2 F8
11 negative regulation of blood coagulation GO:0030195 9.51 PROC PROS1
12 negative regulation of fibrinolysis GO:0051918 9.49 F2 PLG
13 hemostasis GO:0007599 9.23 F2 F3 F5 F8 PLG PROC

Molecular functions related to Vein Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 peptidase activity GO:0008233 9.65 ADAM17 F2 PLAT PLG PROC
2 copper ion binding GO:0005507 9.33 ALB F5 F8
3 serine-type peptidase activity GO:0008236 9.26 F2 PLAT PLG PROC
4 serine-type endopeptidase activity GO:0004252 9.02 F2 F3 PLAT PLG PROC

Sources for Vein Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....